Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Lenalidomide for the treatment of relapsed multiple myeloma.

Gajraj E, Chung H, Boysen M, Barnett DB, Longson C.

Lancet Oncol. 2009 Jul;10(7):647-8. No abstract available.

PMID:
19585686
2.

The UK's NHS and pharma: need for more clinical pharmacologists.

Aronson JK, Barnett DB, Breckenridge AM, Ferner RE, Jackson P, Maxwell SR, McInnes GT, Rawlins MD, Ritter JM, Routledge P, Walley TJ, Webb DJ, Williams D, Woods KL.

Lancet. 2009 Apr 11;373(9671):1251-2. doi: 10.1016/S0140-6736(09)60726-1. No abstract available.

PMID:
19362673
3.

Poor prescribing is continual.

Aronson JK, Barnett DB, Ferner RE, Ferro A, Henderson G, Maxwell SR, Rawlins MD, Webb DJ.

BMJ. 2006 Oct 7;333(7571):756. No abstract available.

4.

Is warfarin a contraindication to thrombolysis in acute ST elevation myocardial infarction?

Stanley AG, Fletcher S, Tan A, Barnett DB.

Heart. 2006 Aug;92(8):1145-146. No abstract available.

5.
6.

The governance of innovation.

Campbell WB, Barnett DB.

Br J Surg. 2004 Dec;91(12):1536-7. No abstract available.

PMID:
15549780
7.

Optimizing liquid effluent monitoring at a large nuclear complex.

Chou CJ, Barnett DB, Johnson VG, Olson PM.

Environ Manage. 2003 Dec;32(6):720-34.

PMID:
15160897
8.
9.
10.

Application of intrawell testing of RCRA groundwater monitoring data when no upgradient well exists.

Chou CJ, O'Brien RF, Barnett DB.

Environ Monit Assess. 2001 Sep;71(1):91-106.

PMID:
11589498
11.

Mechanism and clinical significance of precordial ST depression in inferior myocardial infarction: evaluation by contrast-enhanced dynamic myocardial perfusion magnetic resonance imaging.

Cullen JH, Cherryman GR, Samani NJ, Tranter J, Jivan A, Horsfield MA, Woods KL, Barnett DB.

J Cardiovasc Magn Reson. 1999;1(2):121-30.

PMID:
11550344
12.

Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis.

Talwar S, Downie PF, Squire IB, Davies JE, Barnett DB, Ng LL.

Eur J Heart Fail. 2001 Jan;3(1):15-9.

13.

Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction.

Talwar S, Squire IB, Downie PF, Mccullough AM, Campton MC, Davies JE, Barnett DB, Ng LL.

Eur Heart J. 2000 Sep;21(18):1514-21.

PMID:
10973765
14.

Increased risk of infection with Helicobacter pylori in spouses of infected subjects: observations in a general population sample from the UK.

Stone MA, Taub N, Barnett DB, Mayberry JF.

Hepatogastroenterology. 2000 Mar-Apr;47(32):433-6.

PMID:
10791206
15.

Cancer registries in the Caribbean.

Barnett DB.

West Indian Med J. 1999 Dec;48(4):171-2. No abstract available. Erratum in: West Indian Med J 2000 Mar;49(1):82.

PMID:
10639832
16.
17.
18.

Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: implications for assessment of left ventricular dysfunction.

Downie PF, Talwar S, Squire IB, Davies JE, Barnett DB, Ng LL.

Clin Sci (Lond). 1999 Sep;97(3):255-8.

PMID:
10464049
19.

An immunoluminometric assay for cardiotrophin-1: a newly identified cytokine is present in normal human plasma and is increased in heart failure.

Talwar S, Downie PF, Squire IB, Barnett DB, Davies JD, Ng LL.

Biochem Biophys Res Commun. 1999 Aug 11;261(3):567-71.

PMID:
10441467
20.

A myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging.

Cullen JH, Horsfield MA, Reek CR, Cherryman GR, Barnett DB, Samani NJ.

J Am Coll Cardiol. 1999 Apr;33(5):1386-94.

21.

Results of Helicobacter pylori screening and eradication in a multi-ethnic community in central England.

Stone MA, Patel H, Panja KK, Barnett DB, Mayberry JF.

Eur J Gastroenterol Hepatol. 1998 Nov;10(11):957-62.

PMID:
9872619
22.
23.

General population screening for infection with Helicobacter pylori: a realistic option?

Stone MA, Barnett DB, Mayberry JF.

J Med Screen. 1998;5(3):162-6.

PMID:
9795878
24.

Reasons for non-compliance with screening for infection with Helicobacter pylori, in a multi-ethnic community in Leicester, UK.

Stone MA, Patel H, Panja KK, Barnett DB, Mayberry JF.

Public Health. 1998 May;112(3):153-6.

PMID:
9629021
25.

Magnesium in in-hospital cardiac arrest.

Hassan TB, Barnett DB.

Lancet. 1998 Feb 7;351(9100):445-6. No abstract available.

PMID:
9482330
26.

Cervical cancer screening programs: technical cooperation in the Caribbean.

Barnett DB.

Bull Pan Am Health Organ. 1996 Dec;30(4):409-12.

PMID:
9041754
27.

Magnesium in acute myocardial infarction.

Woods KL, Barnett DB.

BMJ. 1995 Jun 24;310(6995):1669-70. No abstract available.

28.

Beta adrenoceptor density in the donor heart: a guide to prognosis?

Chester MR, Amadi AA, Barnett DB.

Br Heart J. 1995 Jun;73(6):540-3.

29.

Cardiac chamber-specific beta-adrenoceptor regulation and sympathetic innervation.

Chester MR, Barnett DB.

Lancet. 1995 Mar 4;345(8949):553-5.

PMID:
7776776
30.

Long-term evaluation of treatment for chronic heart failure: a 1 year comparative trial of flosequinan and captopril.

Cowley AJ, McEntegart DJ, Hampton JR, Barnett DB, Bexton RS, Boyle R, Hanley SP, Millar-Craig M, Morris GK, Nicholls AJ, et al.

Cardiovasc Drugs Ther. 1994 Dec;8(6):829-36.

PMID:
7742261
31.

What ever happened to the 'general physician'?

Barnett DB.

J R Coll Physicians Lond. 1994 Jul-Aug;28(4):381-2. No abstract available.

32.

Beta-blockers in heart failure: a therapeutic paradox.

Barnett DB.

Lancet. 1994 Mar 5;343(8897):557-8. No abstract available.

PMID:
7906326
34.

Beta adrenergic and muscarinic receptors in compensatory cardiac hypertrophy of the adult rat.

Mansier P, Chevalier B, Barnett DB, Swynghedauw B.

Pflugers Arch. 1993 Aug;424(3-4):354-60.

PMID:
8414922
35.

Subtype selective regulation of coupling of rat cardiac beta adrenoceptors to adenylate cyclase.

Arnold IR, Mistry R, Barnett DB.

Eur J Pharmacol. 1993 May 15;245(3):285-9.

PMID:
8392940
36.

Diagnosis of symptomless left ventricular dysfunction.

Barnett DB.

Lancet. 1993 May 1;341(8853):1124-5. No abstract available.

PMID:
8097808
37.

Flosequinan.

Barnett DB.

Lancet. 1993 Mar 20;341(8847):733-6. Review. No abstract available.

PMID:
8095635
38.

The human platelet fibrinogen receptor: clinical and therapeutic significance.

Cahill M, Mistry R, Barnett DB.

Br J Clin Pharmacol. 1992 Jan;33(1):3-9. Review. No abstract available.

39.

Effects of age, sex and the oral contraceptive on the platelet membrane fibrinogen binding site (glycoprotein IIb/IIIa).

Cahill M, Mistry R, Chapman C, Wood JK, Barnett DB.

Br J Clin Pharmacol. 1992 Jan;33(1):11-5.

40.

Catamenial epilepsy and goserelin.

Haider Y, Barnett DB.

Lancet. 1991 Dec 14;338(8781):1530. No abstract available.

PMID:
1683955
41.

125I-fibrinogen binding to platelets in myeloproliferative disease.

Mistry R, Cahill M, Chapman C, Wood JK, Barnett DB.

Thromb Haemost. 1991 Sep 2;66(3):329-33.

PMID:
1746004
42.

Assessment of quality of life.

Barnett DB.

Am J Cardiol. 1991 May 6;67(12):41C-44C.

PMID:
2021119
43.

Cardiac beta-adrenoceptor regulation and the effects of partial agonism.

Barnett DB, Lu XY.

Am J Cardiol. 1991 May 6;67(12):18C-19C.

PMID:
1673585
44.

The effects of flosequinan on regional blood flow in normal man.

Scott RA, Woods KL, Barnett DB.

Br J Clin Pharmacol. 1991 Jan;31(1):41-6.

45.
46.
47.

Angiotensin converting enzyme inhibitors.

Scott RA, Barnett DB.

Am Heart J. 1989 Dec;118(6):1358-9. No abstract available.

PMID:
2589180
48.

Myocardial beta-adrenoceptor function and regulation in heart failure: implications for therapy.

Barnett DB.

Br J Clin Pharmacol. 1989 May;27(5):527-37. Review. No abstract available.

50.

Effects of calcium channel blockers on in vitro platelet function in whole blood using single platelet counting.

Walley TJ, Woods KL, Barnett DB.

Thromb Haemost. 1989 Feb 28;61(1):137-9.

PMID:
2749586

Supplemental Content

Loading ...
Support Center